Connect with SHL Group at Outsourced Pharma 2017 San Francisco
SHL Group is excited to announce our participation as an exhibitor at Outsourced Pharma 2017 in San Francisco, CA from October 17-18. SHL will show a wide range of capabilities assembling, labeling, and packaging for autoinjectors and pen injectors at Booth 63. We look forward to welcoming pharma’s best and brightest and helping them meet their clinical and commercial needs, from innovative device design through to world-class device assembly, labeling, and packaging.
The rapid growth of the biologics and biosimilars market has created a significant demand for self-injection devices for the treatment of chronic indications. Biologics are often prescribed for chronic conditions where patients need frequent injections and are often required to self-administer medications at home. Biologic drug products have been growing significantly in market share the last few years. Currently, the number of biotechnology products under development exceeds that of conventional drug products. With the increased market share of biologic drugs and the growth in the biosimilar market, SHL is planning for the future with new, innovative drug delivery devices focused on the patient’s needs and building an infrastructure to streamline the development process.
To learn more about our injection devices, visit us at Booth 63 at the Hyatt Regency San Francisco Airport.
